These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29473325)

  • 1. Cheminformatics Analysis of Dynamic WNK-Inhibitor Interactions.
    Kuenemann MA; Fourches D
    Mol Inform; 2018 Jul; 37(6-7):e1700138. PubMed ID: 29473325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating specificity of an allosteric inhibitor WNK476 among With-No-Lysine kinase isoforms using molecular dynamic simulations.
    Amarnath Jonniya N; Sk MF; Kar P
    Chem Biol Drug Des; 2021 Sep; 98(3):405-420. PubMed ID: 33969941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating specificity of the anti-hypertensive inhibitor WNK463 against With-No-Lysine kinase family isoforms via multiscale simulations.
    Jonniya NA; Kar P
    J Biomol Struct Dyn; 2020 Mar; 38(5):1306-1321. PubMed ID: 31017050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing an allosteric inhibitor-induced inactive state in with-no-lysine kinase 1 using Gaussian accelerated molecular dynamics simulations.
    Jonniya NA; Sk MF; Kar P
    Phys Chem Chem Phys; 2021 Mar; 23(12):7343-7358. PubMed ID: 33876094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of structural and conformational properties of WNK kinase isoforms bound to an inhibitor: insights from molecular dynamic simulations.
    Jonniya NA; Sk MF; Kar P
    J Biomol Struct Dyn; 2022 Feb; 40(3):1400-1415. PubMed ID: 33016858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule WNK inhibition regulates cardiovascular and renal function.
    Yamada K; Park HM; Rigel DF; DiPetrillo K; Whalen EJ; Anisowicz A; Beil M; Berstler J; Brocklehurst CE; Burdick DA; Caplan SL; Capparelli MP; Chen G; Chen W; Dale B; Deng L; Fu F; Hamamatsu N; Harasaki K; Herr T; Hoffmann P; Hu QY; Huang WJ; Idamakanti N; Imase H; Iwaki Y; Jain M; Jeyaseelan J; Kato M; Kaushik VK; Kohls D; Kunjathoor V; LaSala D; Lee J; Liu J; Luo Y; Ma F; Mo R; Mowbray S; Mogi M; Ossola F; Pandey P; Patel SJ; Raghavan S; Salem B; Shanado YH; Trakshel GM; Turner G; Wakai H; Wang C; Weldon S; Wielicki JB; Xie X; Xu L; Yagi YI; Yasoshima K; Yin J; Yowe D; Zhang JH; Zheng G; Monovich L
    Nat Chem Biol; 2016 Nov; 12(11):896-898. PubMed ID: 27595330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening.
    Chlebowicz J; Akella R; Humphreys JM; He H; Kannangara AR; Wei S; Posner B; Goldsmith EJ
    Drug Des Devel Ther; 2023; 17():93-105. PubMed ID: 36712947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models.
    Yamada K; Levell J; Yoon T; Kohls D; Yowe D; Rigel DF; Imase H; Yuan J; Yasoshima K; DiPetrillo K; Monovich L; Xu L; Zhu M; Kato M; Jain M; Idamakanti N; Taslimi P; Kawanami T; Argikar UA; Kunjathoor V; Xie X; Yagi YI; Iwaki Y; Robinson Z; Park HM
    J Med Chem; 2017 Aug; 60(16):7099-7107. PubMed ID: 28771350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium-regulated distal tubule WNK bodies are kidney-specific WNK1 dependent.
    Boyd-Shiwarski CR; Shiwarski DJ; Roy A; Namboodiri HN; Nkashama LJ; Xie J; McClain KL; Marciszyn A; Kleyman TR; Tan RJ; Stolz DB; Puthenveedu MA; Huang CL; Subramanya AR
    Mol Biol Cell; 2018 Feb; 29(4):499-509. PubMed ID: 29237822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phosphorylated Intermediate in the Activation of WNK Kinases.
    Akella R; Drozdz MA; Humphreys JM; Jiou J; Durbacz MZ; Mohammed ZJ; He H; Liwocha J; Sekulski K; Goldsmith EJ
    Biochemistry; 2020 May; 59(18):1747-1755. PubMed ID: 32314908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3ß functions as a positive effector in the WNK signaling pathway.
    Sato A; Shibuya H
    PLoS One; 2018; 13(3):e0193204. PubMed ID: 29494638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Characterization of Allosteric WNK Kinase Inhibitors.
    Yamada K; Zhang JH; Xie X; Reinhardt J; Xie AQ; LaSala D; Kohls D; Yowe D; Burdick D; Yoshisue H; Wakai H; Schmidt I; Gunawan J; Yasoshima K; Yue QK; Kato M; Mogi M; Idamakanti N; Kreder N; Drueckes P; Pandey P; Kawanami T; Huang W; Yagi YI; Deng Z; Park HM
    ACS Chem Biol; 2016 Dec; 11(12):3338-3346. PubMed ID: 27712055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmosensing by WNK Kinases.
    Akella R; Humphreys JM; Sekulski K; He H; Durbacz M; Chakravarthy S; Liwocha J; Mohammed ZJ; Brautigam CA; Goldsmith EJ
    Mol Biol Cell; 2021 Aug; 32(18):1614-1623. PubMed ID: 33689398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Docking Studies of New Torin2 Analogs as Potential ATR/mTOR Kinase Inhibitors.
    Shaik A; Bhakuni R; Kirubakaran S
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29695073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
    Sohara E; Uchida S
    Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging unique structural characteristics of WNK kinases to achieve therapeutic inhibition.
    Zhang J; Deng X; Kahle KT
    Sci Signal; 2016 Oct; 9(450):e3. PubMed ID: 27811182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potential competitive inhibitors against With-No-Lysine kinase 1 for treating hypertension by virtual screening, inverse pharmacophore-based lead optimization, and molecular dynamics simulations.
    Jonniya NA; Sk MF; Roy R; Kar P
    SAR QSAR Environ Res; 2022 Feb; 33(2):63-87. PubMed ID: 35078380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking/dynamics studies of Aurora A kinase inhibitors.
    Talele TT; McLaughlin ML
    J Mol Graph Model; 2008 Jun; 26(8):1213-22. PubMed ID: 18096419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Phase for WNK Kinase Signaling Complexes as Biomolecular Condensates.
    Boyd-Shiwarski CR; Shiwarski DJ; Subramanya AR
    Physiology (Bethesda); 2024 Sep; 39(5):0. PubMed ID: 38624245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico 3D structure modeling and inhibitor binding studies of human male germ cell-associated kinase.
    Tanneeru K; Balla AR; Guruprasad L
    J Biomol Struct Dyn; 2015; 33(8):1710-9. PubMed ID: 25245460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.